WHO ICTRP trial
A phase III study of KW-3357
JPRN-jRCT2080221496 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080221496 |
|---|---|
| Public title | A phase III study of KW-3357 |
| Scientific title | A clinical study of KW-3357 in patients diagnosed as disseminated intravascular coagulation (DIC) by the diagnostic criteria for DIC established by the Japanese Ministry of Health and Welfare |
| Primary sponsor | Kyowa Hakko Kirin Co., Ltd. |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Disseminated intravascular coagulation (DIC) |
| Interventions | investigational material(s) Generic name etc : KW-3357 INN of investigational material : Therapeutic category code : 634 Human blood preparations Dosage and Administration for Investigational material : Intravenous infusion once a day |
| Registration date | Jun 28, 2011 |
| Secondary IDs | JapicCTI-111535 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: